As of 2025-07-01, the Intrinsic Value of Field Trip Health Ltd (FTRP.TO) is (6,732.47) CAD. This FTRP.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.74 CAD, the upside of Field Trip Health Ltd is -180,112.60%.
The range of the Intrinsic Value is (25,410.14) - (3,907.32) CAD
Based on its market price of 3.74 CAD and our intrinsic valuation, Field Trip Health Ltd (FTRP.TO) is overvalued by 180,112.60%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (25,410.14) - (3,907.32) | (6,732.47) | -180112.6% |
| DCF (Growth 10y) | (60,155.94) - (417,449.11) | (107,060.48) | -2862679.7% |
| DCF (EBITDA 5y) | (2,426.74) - (2,889.92) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (37,996.50) - (48,896.00) | (1,234.50) | -123450.0% |
| Fair Value | -15.43 - -15.43 | -15.43 | -512.49% |
| P/E | (36.04) - (49.06) | (42.66) | -1240.5% |
| EV/EBITDA | (49.92) - (33.52) | (44.07) | -1278.2% |
| EPV | (9.55) - (13.15) | (11.35) | -403.5% |
| DDM - Stable | (35.46) - (181.21) | (108.33) | -2996.6% |
| DDM - Multi | (2,099.31) - (8,528.28) | (3,392.35) | -90804.5% |
| Market Cap (mil) | 66.29 |
| Beta | 1.04 |
| Outstanding shares (mil) | 17.73 |
| Enterprise Value (mil) | 31.63 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.81% |
| Cost of Debt | 5.00% |
| WACC | 6.56% |